Vaxcyte, Inc..
PCVX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Vaxcyte, Inc. is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of infectious diseases. The company is focused on developing prophylactic vaccines to address the limitations of current vaccines and address the unmet needs in ...Show More
Better Health for All
0
No evidence available to assess Vaxcyte, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Vaxcyte, Inc. is a clinical-stage vaccine innovation company focused on developing vaccines, not a financial institution.
1
The provided articles consistently confirm that the company's core business does not involve lending, insuring, moving, or storing money for consumers or businesses. Therefore, all KPIs under 'Fair Money & Economic Opportunity' are not applicable to Vaxcyte's operations, as explicitly stated in multiple articles.
2
Fair Pay & Worker Respect
10
The CEO pay ratio for the 2024 fiscal year was 123:1.
1
Employee satisfaction, based on 22 reviews, is 4.1 out of 5 stars, with 83% of employees indicating they would recommend working at the company.
2
No specific regulatory actions, violations, fines, or compliance issues related to labor were mentioned in the provided reviews.
3
Fair Trade & Ethical Sourcing
0
The provided article, a summary of Vaxcyte, Inc.'s annual report, does not contain any specific, concrete data points or facts related to fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical sourcing clauses in contracts, spend on high-risk materials, or supplier diversity.
1
The article explicitly notes "Limited information on fair trade, ethical sourcing, audits, and remediation."
2
Therefore, no KPIs under the Fair Trade & Ethical Sourcing value can be scored based on the available evidence.
Honest & Fair Business
0
The provided articles do not contain specific, quantitative data points for any of the KPIs related to the 'Honest & Fair Business' ethical value. Information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification is not available in the provided evidence.
1
Kind to Animals
-70
Vaxcyte does not have any products certified cruelty-free, with 0% of its portfolio holding such certifications.
1
The company explicitly conducts animal testing for pre-clinical safety and efficacy assessments, including studies using ten rhesus macaques and multiple groups of mice.
2
While a predecessor or related entity, VaxDesign, developed simulated human immune systems as an alternative to animal studies in 2008, Vaxcyte's current research still heavily relies on animal models, suggesting alternative assays are used sporadically.
3
The company's animal testing policy prohibits discretionary testing, but legal mandates still override alternatives, and research is conducted under Institutional Animal Care and Use Committee (IACUC) approved protocols in compliance with the Animal Welfare Act and NIH guidelines.
4
The company received a cost-reimbursement research award of up to $2.7 million from CARB-X in 2019 to support vaccine development, but less than 1% of its R&D budget is explicitly stated to be for animal-free technologies.
5
There is no formal collaboration or significant engagement with animal welfare stakeholders to develop industry-wide animal-free testing standards, nor does the company take a public position on animal welfare legislation.
No War, No Weapons
0
The provided articles, which include financial reports, explicitly state 'Not applicable' or 'No information found' for every KPI related to the 'No War, No Weapons' value.
1
There is no specific, concrete data point, event, policy, or action mentioned in the articles that can be used to score any of the KPIs.
2
Therefore, all KPIs must be omitted due to lack of evidence.
Planet-Friendly Business
0
No quantitative data or specific metrics related to planet-friendly business practices, such as emissions, renewable energy, water usage, waste diversion, or environmental compliance, were found in the provided articles.
1
The articles primarily focus on company operations, clinical trials, and general ESG risk scores without detailing specific environmental performance indicators.
Respect for Cultures & Communities
0
The provided articles focus on Vaxcyte's clinical-stage vaccine development, financial updates, and internal company culture. No specific, concrete data points or information related to formal partnerships with community groups, revenue reinvested in local development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, grievance mechanisms, FPIC participation, community governance inclusion, cultural preservation investment, local procurement, indigenous suppliers, cultural site protection, social license to operate, charitable giving to cultural organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training were found.
1
Safe & Smart Tech
0
Vaxcyte, Inc. reports that cybersecurity threats have not materially affected them to date, and no specific data breach incidents or unauthorized data use incidents have been reported.
1
The company conducts security awareness training for employees, performs vulnerability assessments, penetration testing, and third-party threat assessments, and conducts security testing.
2
Encryption of certain data and authentication methods are also mentioned.
3
However, no specific metrics on the effectiveness of training, the scope or strength of encryption, details on authentication methods, vulnerability remediation timeframes, or the scope and frequency of security testing are provided.
4
Zero Waste & Sustainable Products
0
No specific, quantitative data related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education for Vaxcyte, Inc. is provided in the available articles.
1
The reports explicitly state a lack of meaningful data on the company's sustainability practices relevant to these metrics.
2